Analysts Set Avantor, Inc. (NYSE:AVTR) Price Target at $12.00

Shares of Avantor, Inc. (NYSE:AVTR) have been assigned an average recommendation of “Hold” from the eighteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, fifteen have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $12.00.

A number of analysts recently commented on AVTR shares. Wells Fargo & Company boosted their price objective on shares of Avantor from $14.00 to $16.00 and gave the stock an “overweight” rating in a report on Thursday, July 30th. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. TD Cowen reiterated a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Finally, Sanford C. Bernstein initiated coverage on Avantor in a report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price target on the stock.

Avantor Trading Up 2.1%

NYSE AVTR opened at $14.26 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a market cap of $9.64 billion, a PE ratio of -16.98, a P/E/G ratio of 10.54 and a beta of 0.89. Avantor has a one year low of $7.26 and a one year high of $15.93. The firm’s fifty day moving average is $11.53 and its two-hundred day moving average is $9.61.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The company had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same period last year, the firm earned $0.24 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Analysts expect that Avantor will post 0.81 earnings per share for the current year.

Key Avantor News

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Zacks raised its EPS forecasts for Avantor’s fiscal 2026 to $0.80 from $0.78, fiscal 2027 to $0.85 from $0.84, and fiscal 2028 to $0.92 from $0.91. It also increased its Q2 2027 estimate to $0.22 from $0.19 and Q2 2028 to $0.23 from $0.22. The upward full-year revisions may support the stock by signaling improving earnings prospects.
• Neutral Sentiment: Zacks maintained a “Hold” rating on AVTR. Its fiscal 2026 estimate of $0.80 remains slightly below the broader consensus of $0.81, limiting the strength of the positive signal.
• Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $0.22 from $0.23, Q1 2027 to $0.18 from $0.19, and Q3 2027 to $0.22 from $0.23. These reductions point to some near-term earnings pressure and partially offset the longer-term upgrades.
• Neutral Sentiment: Recent coverage also focused on Avantor’s results and its performance relative to other medical stocks, but the supplied reports did not provide a new company announcement or additional operating catalyst. Avantor Results Put Market Expectations To Test

Institutional Trading of Avantor

Several large investors have recently bought and sold shares of AVTR. Private Trust Co. NA increased its holdings in shares of Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after buying an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after acquiring an additional 905 shares during the last quarter. Osaic Holdings Inc. grew its position in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after acquiring an additional 1,064 shares in the last quarter. UMB Bank n.a. grew its position in Avantor by 17.6% in the fourth quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock worth $84,000 after acquiring an additional 1,101 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.